The life sciences and chemical sectors are very strongly represented in Switzerland and constitute a key pillar of the economy.
Within this market, companies are currently starting to move their focus back to Switzerland again. Production is returning to Switzerland,
and companies that are established here are investing in their home location to a greater extent once more.
The Basel conurbation is one of Europe’s biggest life sciences regions. Almost two thirds of those employed in the Swiss pharmaceutical industry
work in this cluster. In addition, a major portion of the Swiss added value chain is generated in Basel and its surroundings.
Around one third of all Swiss exports and a fifth of all Swiss imports are attributable to pharmaceutical products.
Global sales of the top ten Swiss chemical and pharmaceutical companies totalled CHF 147 thousand million in 2017.